Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Article, Research Support, Non-U.S. Gov’t, Archiv der Pharmazie (Weinheim, Germany) called Design, Synthesis, and Antifungal Activity of Novel Conformationally Restricted Triazole Derivatives, Author is Wang, Wenya; Sheng, Chunquan; Che, Xiaoying; Ji, Haitao; Miao, Zhenyuan; Yao, Jianzhong; Zhang, Wannian, which mentions a compound: 86404-63-9, SMILESS is FC1=CC=C(C(CN2N=CN=C2)=O)C(F)=C1, Molecular C10H7F2N3O, Formula: C10H7F2N3O.
A series of new triazole derivatives were designed and synthesized on the basis of the active site of lanosterol 14α-demethylase from Candida albicans (CACYP51). 2-(2,4-Difluorophenyl)-3-(methyl-(3-phenoxyalkyl)amino)-1-(1H-1,2,4-triazol-1-yl)propan-2-ols show excellent in-vitro activity against most of the tested pathogenic fungi. The MIC80 value of compound I against Candida albicans is 0.01 μM, which provides a good starting template for further structural optimization. The binding modes of the designed compounds were investigated by flexible mol. docking. The compounds interacted with CACYP51 through hydrophobic, van-der-Waals, and hydrogen-bonding interactions.
This literature about this compound(86404-63-9)Formula: C10H7F2N3Ohas given us a lot of inspiration, and I hope that the research on this compound(1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone) can be further advanced. Maybe we can get more compounds in a similar way.
Reference:
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics